|
|
Important Safety and Other Information: Lupron Depot-PED (7.5 mg, 11.25 mg, and 15 mg) is used for the treatment of central precocious puberty. In clinical studies, the most frequent adverse event related to therapy with Lupron Depot-PED was an injection site reaction, seen in 5% of children in the combined studies. The recommended starting dose of Lupron Depot-PED is 0.3 mg/kg/4 weeks (minimum 7.5 mg). Inadequate dosing may result in poor control of the pubertal process. For further information about Lupron Depot-PED, please see the complete Prescribing Information, as well as the |
||
|
©2005, 2008 Abbott Laboratories, Abbott Park, Illinois, U.S.A. |